{"transactions":[{"id":941941,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-09T16:30:17.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":1612099,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1612099,"derivative":{"exercise_price":0.055,"exercise_date":"2026-01-07","expiration_date":"2036-01-06","underlying":"Common Stock","underlying_shares":1612099},"source":{"system":"sec-edgar","filing":"0001213900-26-002951","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390026002951/ownership.xml","form_type":"4"}},{"id":1127426,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-02T17:02:49.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":122549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest in equal monthly installments through May 30, 2027."}],"balance_after":122549,"derivative":{"exercise_price":0.4454,"expiration_date":"2035-05-29","underlying":"Common Stock","underlying_shares":122549},"source":{"system":"sec-edgar","filing":"0001213900-25-050113","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390025050113/ownership.xml","form_type":"4"}},{"id":1177494,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Pre-Funded Warrant","published_at":"2025-04-04T19:12:50.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":294460,"price":0.0001,"value":29.446,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants are exercisable at any time on or after the date of issuance for an exercise price of $0.0001 per share, for shares of common stock of the Issuer."}],"balance_after":11660,"derivative":{"exercise_price":0.0001,"exercise_date":"2025-02-07","underlying":"Common Stock","underlying_shares":294460},"source":{"system":"sec-edgar","filing":"0001213900-25-029111","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390025029111/ownership.xml","form_type":"4"}},{"id":1177493,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-04T19:12:50.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":294460,"price":0.0001,"value":29.446,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On March 28, 2025, Mr. Atwood exercised Pre-Funded Warrants (the \"Pre-Funded Warrants\") and directed the issuance of the shares of common stock of CERo Therapeutics Holdings, Inc. (the \"Issuer\") to the Atwood-Edminster Trust dtd 4-2-2000 (the \"Trust\"). Mr. Atwood and his wife are the managers of the LLC and the trustees of the Trust. Accordingly, Mr. Atwood may be deemed to have beneficial ownership of the securities held directly by the LLC.."}],"balance_after":490534,"source":{"system":"sec-edgar","filing":"0001213900-25-029111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390025029111/ownership.xml","form_type":"4"}},{"id":1219293,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-06T16:14:58.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":14936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the 50% time-based portion of an award of options to purchase 29,871 shares, vesting on the twelve month anniversary of the grant date, with the remaining portion subject to performance conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the 50% time-based portion of an award of options to purchase 29,871 shares, vesting on the twelve month anniversary of the grant date, with the remaining portion subject to performance conditions."}],"balance_after":14936,"derivative":{"exercise_price":1.43,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":14936},"source":{"system":"sec-edgar","filing":"0001213900-25-021183","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390025021183/ownership.xml","form_type":"4"}},{"id":1242672,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-26T17:54:18.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":254000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 1, 2024, the Reporting Person was granted an option to purchase 508,000 shares of Common Stock, which vest in two equal installments subject to the satisfaction of certain performance criteria. On February 24, 2025, the Issuer's Board of Directors confirmed that the performance criteria had been met with regards to the second installment, resulting in the vesting of 254,000 shares."}],"balance_after":508000,"derivative":{"exercise_price":0.1,"expiration_date":"2034-09-30","underlying":"Common Stock","underlying_shares":254000},"source":{"system":"sec-edgar","filing":"0001213900-25-017505","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390025017505/ownership.xml","form_type":"4"}},{"id":1278559,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Shares of Common Stock","published_at":"2025-02-07T17:23:22.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":204080,"price":1.9599,"value":399976.392,"ownership":{"direct":false,"nature":"By GVN, LLC"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 7, 2025, pursuant to a Securities Purchase Agreement, dated February 5, 2025, the reporting persons purchased Pre-Funded Warrants, which are exercisable at any time on or after the date of issuance for an exercise price of $0.0001 per share, for shares of common stock of CERo Therapeutics Holdings, Inc. (the \"Issuer\"), and an equal number of Warrants, which will become exercisable immediately upon the Issuer's receipt of stockholder approval (the \"Stockholder Approval Date\") for an exercise price of $1.96 per share, for shares of the Issuer's common stock. The aggregate purchase price for each pair of Pre-Funded Warrants and Warrants was $1.9599. The Warrants will expire on the fifth anniversary of the Stockholder Approval Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 7, 2025, pursuant to a Securities Purchase Agreement, dated February 5, 2025, the reporting persons purchased Pre-Funded Warrants, which are exercisable at any time on or after the date of issuance for an exercise price of $0.0001 per share, for shares of common stock of CERo Therapeutics Holdings, Inc. (the \"Issuer\"), and an equal number of Warrants, which will become exercisable immediately upon the Issuer's receipt of stockholder approval (the \"Stockholder Approval Date\") for an exercise price of $1.96 per share, for shares of the Issuer's common stock. The aggregate purchase price for each pair of Pre-Funded Warrants and Warrants was $1.9599. The Warrants will expire on the fifth anniversary of the Stockholder Approval Date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GVN, LLC (the \"LLC\") is a limited liability company of which the sole member is the Atwood-Edminster Trust dtd 4-2-2000 (the \"Trust\"). Mr. Atwood and his wife are the managers of the LLC and the trustees of the Trust. Accordingly, Mr. Atwood may be deemed to have beneficial ownership of the securities held directly by the LLC."}],"balance_after":204080,"derivative":{"exercise_price":1.96,"underlying":"Common Stock","underlying_shares":204080},"source":{"system":"sec-edgar","filing":"0001213900-25-011409","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390025011409/ownership.xml","form_type":"4"}},{"id":1278558,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Shares of Common Stock","published_at":"2025-02-07T17:23:22.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":306120,"price":1.9599,"value":599964.588,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 7, 2025, pursuant to a Securities Purchase Agreement, dated February 5, 2025, the reporting persons purchased Pre-Funded Warrants, which are exercisable at any time on or after the date of issuance for an exercise price of $0.0001 per share, for shares of common stock of CERo Therapeutics Holdings, Inc. (the \"Issuer\"), and an equal number of Warrants, which will become exercisable immediately upon the Issuer's receipt of stockholder approval (the \"Stockholder Approval Date\") for an exercise price of $1.96 per share, for shares of the Issuer's common stock. The aggregate purchase price for each pair of Pre-Funded Warrants and Warrants was $1.9599. The Warrants will expire on the fifth anniversary of the Stockholder Approval Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 7, 2025, pursuant to a Securities Purchase Agreement, dated February 5, 2025, the reporting persons purchased Pre-Funded Warrants, which are exercisable at any time on or after the date of issuance for an exercise price of $0.0001 per share, for shares of common stock of CERo Therapeutics Holdings, Inc. (the \"Issuer\"), and an equal number of Warrants, which will become exercisable immediately upon the Issuer's receipt of stockholder approval (the \"Stockholder Approval Date\") for an exercise price of $1.96 per share, for shares of the Issuer's common stock. The aggregate purchase price for each pair of Pre-Funded Warrants and Warrants was $1.9599. The Warrants will expire on the fifth anniversary of the Stockholder Approval Date."}],"balance_after":306120,"derivative":{"exercise_price":1.96,"underlying":"Common Stock","underlying_shares":306120},"source":{"system":"sec-edgar","filing":"0001213900-25-011409","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390025011409/ownership.xml","form_type":"4"}},{"id":1278557,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Pre-Funded Warrant","published_at":"2025-02-07T17:23:22.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":204080,"price":0.0001,"value":20.408,"ownership":{"direct":false,"nature":"By GVN, LLC"},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 7, 2025, pursuant to a Securities Purchase Agreement, dated February 5, 2025, the reporting persons purchased Pre-Funded Warrants, which are exercisable at any time on or after the date of issuance for an exercise price of $0.0001 per share, for shares of common stock of CERo Therapeutics Holdings, Inc. (the \"Issuer\"), and an equal number of Warrants, which will become exercisable immediately upon the Issuer's receipt of stockholder approval (the \"Stockholder Approval Date\") for an exercise price of $1.96 per share, for shares of the Issuer's common stock. The aggregate purchase price for each pair of Pre-Funded Warrants and Warrants was $1.9599. The Warrants will expire on the fifth anniversary of the Stockholder Approval Date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GVN, LLC (the \"LLC\") is a limited liability company of which the sole member is the Atwood-Edminster Trust dtd 4-2-2000 (the \"Trust\"). Mr. Atwood and his wife are the managers of the LLC and the trustees of the Trust. Accordingly, Mr. Atwood may be deemed to have beneficial ownership of the securities held directly by the LLC."}],"balance_after":204080,"derivative":{"exercise_price":0.0001,"exercise_date":"2025-02-07","underlying":"Common Stock","underlying_shares":204080},"source":{"system":"sec-edgar","filing":"0001213900-25-011409","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390025011409/ownership.xml","form_type":"4"}},{"id":1278556,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Pre-Funded Warrant","published_at":"2025-02-07T17:23:22.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":306120,"price":0.0001,"value":30.612,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 7, 2025, pursuant to a Securities Purchase Agreement, dated February 5, 2025, the reporting persons purchased Pre-Funded Warrants, which are exercisable at any time on or after the date of issuance for an exercise price of $0.0001 per share, for shares of common stock of CERo Therapeutics Holdings, Inc. (the \"Issuer\"), and an equal number of Warrants, which will become exercisable immediately upon the Issuer's receipt of stockholder approval (the \"Stockholder Approval Date\") for an exercise price of $1.96 per share, for shares of the Issuer's common stock. The aggregate purchase price for each pair of Pre-Funded Warrants and Warrants was $1.9599. The Warrants will expire on the fifth anniversary of the Stockholder Approval Date."}],"balance_after":306120,"derivative":{"exercise_price":0.0001,"exercise_date":"2025-02-07","underlying":"Common Stock","underlying_shares":306120},"source":{"system":"sec-edgar","filing":"0001213900-25-011409","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390025011409/ownership.xml","form_type":"4"}},{"id":1342728,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-04T21:11:38.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":254000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 1, 2024, the Reporting Person was granted an option to purchase 508,000 shares of Common Stock, which vest in two equal installments subject to the satisfaction of certain performance criteria. On December 2, 2024, the Issuer's Board of Directors confirmed that the performance criteria had been met with regards to one installment, resulting in the vesting of 254,000 shares."}],"balance_after":254000,"derivative":{"exercise_price":0.1,"expiration_date":"2034-09-30","underlying":"Common Stock","underlying_shares":254000},"source":{"system":"sec-edgar","filing":"0001213900-24-105726","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390024105726/ownership.xml","form_type":"4"}},{"id":1393975,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-02T21:52:20.000Z","date":"2024-09-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1317956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the forfeiture of employee stock options in connection with the Reporting Person's resignation as Chief Executive Officer of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents the forfeiture of employee stock options in connection with the Reporting Person's resignation as Chief Executive Officer of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":1.77,"expiration_date":"2034-03-24","underlying":"Common Stock","underlying_shares":1317956},"source":{"system":"sec-edgar","filing":"0001213900-24-084829","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390024084829/ownership.xml","form_type":"4"}},{"id":1393974,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-02T21:52:20.000Z","date":"2024-09-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the forfeiture of employee stock options in connection with the Reporting Person's resignation as Chief Executive Officer of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents the forfeiture of employee stock options in connection with the Reporting Person's resignation as Chief Executive Officer of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":5.28,"expiration_date":"2030-12-27","underlying":"Common Stock","underlying_shares":13857},"source":{"system":"sec-edgar","filing":"0001213900-24-084829","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390024084829/ownership.xml","form_type":"4"}},{"id":1393973,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-10-02T21:52:20.000Z","date":"2024-09-25","kind":"exercise","planned":false,"acquired":false,"shares":1002,"price":1000,"value":1002000.0,"ownership":{"direct":false,"nature":"Atwood-Edminster Trust dtd 4-2-2000"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 25, 2024, the Reporting Person converted an aggregate of 1,002 shares of Series A Preferred Stock into 19,358,578 shares of Common Stock. Each share of Series A Preferred Stock has a stated value of $1,000 and, at the option of the holder, is convertible into a number of shares of Common Stock determined by dividing (x) the value of the shares of Series A Preferred Stock, plus any additional amounts thereon as of such date of determination, by (y) the conversion price of $1.00. As a result of various adjustments in the terms of the Series A Preferred Stock, each $1,000 of Series A Preferred Stock was converted into 19,320 shares of common stock. The Series A Preferred Stock has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 25, 2024, the Reporting Person converted an aggregate of 1,002 shares of Series A Preferred Stock into 19,358,578 shares of Common Stock. Each share of Series A Preferred Stock has a stated value of $1,000 and, at the option of the holder, is convertible into a number of shares of Common Stock determined by dividing (x) the value of the shares of Series A Preferred Stock, plus any additional amounts thereon as of such date of determination, by (y) the conversion price of $1.00. As a result of various adjustments in the terms of the Series A Preferred Stock, each $1,000 of Series A Preferred Stock was converted into 19,320 shares of common stock. The Series A Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 25, 2024, the Reporting Person converted an aggregate of 1,002 shares of Series A Preferred Stock into 19,358,578 shares of Common Stock. Each share of Series A Preferred Stock has a stated value of $1,000 and, at the option of the holder, is convertible into a number of shares of Common Stock determined by dividing (x) the value of the shares of Series A Preferred Stock, plus any additional amounts thereon as of such date of determination, by (y) the conversion price of $1.00. As a result of various adjustments in the terms of the Series A Preferred Stock, each $1,000 of Series A Preferred Stock was converted into 19,320 shares of common stock. The Series A Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 25, 2024, the Reporting Person converted an aggregate of 1,002 shares of Series A Preferred Stock into 19,358,578 shares of Common Stock. Each share of Series A Preferred Stock has a stated value of $1,000 and, at the option of the holder, is convertible into a number of shares of Common Stock determined by dividing (x) the value of the shares of Series A Preferred Stock, plus any additional amounts thereon as of such date of determination, by (y) the conversion price of $1.00. As a result of various adjustments in the terms of the Series A Preferred Stock, each $1,000 of Series A Preferred Stock was converted into 19,320 shares of common stock. The Series A Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the trustee of the Atwood-Edminster Trust dtd 4-2-2000 (the \"Atwood-Edminster Trust\") and has sole voting and disposition power with respect to the shares owned by the Atwood-Edminster Trust."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":19358578},"source":{"system":"sec-edgar","filing":"0001213900-24-084829","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390024084829/ownership.xml","form_type":"4"}},{"id":1393972,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T21:52:20.000Z","date":"2024-09-25","kind":"exercise","planned":false,"acquired":true,"shares":19358578,"ownership":{"direct":false,"nature":"Atwood-Edminster Trust dtd 4-2-2000"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 25, 2024, the Reporting Person converted an aggregate of 1,002 shares of Series A Preferred Stock into 19,358,578 shares of Common Stock. Each share of Series A Preferred Stock has a stated value of $1,000 and, at the option of the holder, is convertible into a number of shares of Common Stock determined by dividing (x) the value of the shares of Series A Preferred Stock, plus any additional amounts thereon as of such date of determination, by (y) the conversion price of $1.00. As a result of various adjustments in the terms of the Series A Preferred Stock, each $1,000 of Series A Preferred Stock was converted into 19,320 shares of common stock. The Series A Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 25, 2024, the Reporting Person converted an aggregate of 1,002 shares of Series A Preferred Stock into 19,358,578 shares of Common Stock. Each share of Series A Preferred Stock has a stated value of $1,000 and, at the option of the holder, is convertible into a number of shares of Common Stock determined by dividing (x) the value of the shares of Series A Preferred Stock, plus any additional amounts thereon as of such date of determination, by (y) the conversion price of $1.00. As a result of various adjustments in the terms of the Series A Preferred Stock, each $1,000 of Series A Preferred Stock was converted into 19,320 shares of common stock. The Series A Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the trustee of the Atwood-Edminster Trust dtd 4-2-2000 (the \"Atwood-Edminster Trust\") and has sole voting and disposition power with respect to the shares owned by the Atwood-Edminster Trust."}],"balance_after":19607313,"source":{"system":"sec-edgar","filing":"0001213900-24-084829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390024084829/ownership.xml","form_type":"4"}},{"id":1559396,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-27T21:24:22.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":1317956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest as follows: 732,198 shares are immediately vested and exercisable, and the remainder shall vest in forty-eight (48) monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":1317956,"derivative":{"exercise_price":1.77,"expiration_date":"2034-03-24","underlying":"Common Stock","underlying_shares":1317956},"source":{"system":"sec-edgar","filing":"0001213900-24-026814","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390024026814/ownership.xml","form_type":"4"}},{"id":1583892,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-11T19:23:59.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":13857,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Atwood-Edminster Trust dtd 4-2-2000"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents an option to purchase the Issuer's Common Stock that was converted from the then outstanding CERo Therapeutics, Inc. option immediately prior to the consummation of the Issuer's business combination. The option is fully vested."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the trustee of the Atwood-Edminster Trust dtd 4-2-2000 (the \"Atwood-Edminster Trust\") and has sole voting and disposition power with respect to the shares owned by the Atwood-Edminster Trust."}],"balance_after":13857,"derivative":{"exercise_price":5.28,"expiration_date":"2030-12-27","underlying":"Common Stock","underlying_shares":13857},"source":{"system":"sec-edgar","filing":"0001213900-24-021525","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390024021525/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-16"}},{"id":1583891,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-03-11T19:23:59.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":1002,"price":1000,"value":1002000.0,"ownership":{"direct":false,"nature":"Atwood-Edminster Trust dtd 4-2-2000"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On February 14, 2024, the Atwood-Edminster Trust acquired 1,002 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 5, 2024. Each share of Series A Preferred Stock has a stated value of $1,000 and, at the option of the holder, is convertible into a number of shares of Common Stock determined by dividing (x) the value of the shares of Series A Preferred Stock, plus any additional amounts thereon as of such date of determination, by (y) the conversion price, which is currently $10.00, subject to adjustments (the \"Conversion Price\"). The Series A Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 14, 2024, the Atwood-Edminster Trust acquired 1,002 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 5, 2024. Each share of Series A Preferred Stock has a stated value of $1,000 and, at the option of the holder, is convertible into a number of shares of Common Stock determined by dividing (x) the value of the shares of Series A Preferred Stock, plus any additional amounts thereon as of such date of determination, by (y) the conversion price, which is currently $10.00, subject to adjustments (the \"Conversion Price\"). The Series A Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 14, 2024, the Atwood-Edminster Trust acquired 1,002 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 5, 2024. Each share of Series A Preferred Stock has a stated value of $1,000 and, at the option of the holder, is convertible into a number of shares of Common Stock determined by dividing (x) the value of the shares of Series A Preferred Stock, plus any additional amounts thereon as of such date of determination, by (y) the conversion price, which is currently $10.00, subject to adjustments (the \"Conversion Price\"). The Series A Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the trustee of the Atwood-Edminster Trust dtd 4-2-2000 (the \"Atwood-Edminster Trust\") and has sole voting and disposition power with respect to the shares owned by the Atwood-Edminster Trust."}],"balance_after":1002,"derivative":{"exercise_price":10,"underlying":"Common Stock","underlying_shares":100200},"source":{"system":"sec-edgar","filing":"0001213900-24-021525","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390024021525/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-16"}},{"id":1583890,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-11T19:23:59.000Z","date":"2024-02-14","kind":"other","planned":false,"acquired":true,"shares":148208,"ownership":{"direct":false,"nature":"Atwood-Edminster Trust dtd 4-2-2000"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Common Stock issued to the Atwood-Edminster Trust (as defined below) in connection with the Issuer's business combination consummated on February 14, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the trustee of the Atwood-Edminster Trust dtd 4-2-2000 (the \"Atwood-Edminster Trust\") and has sole voting and disposition power with respect to the shares owned by the Atwood-Edminster Trust."}],"balance_after":248735,"source":{"system":"sec-edgar","filing":"0001213900-24-021525","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390024021525/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-16"}},{"id":1583889,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-11T19:23:59.000Z","date":"2024-02-14","kind":"other","planned":false,"acquired":true,"shares":100527,"ownership":{"direct":false,"nature":"Atwood-Edminster Trust dtd 4-2-2000"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents earnout shares, each of which consist of one share of the Issuer's Common Stock, subject to forfeiture if certain vesting conditions are not satisfied. The earnout shares vest as follows: (i) 33,045 shares if the volume weighted average price (\"VWAP\") of the Common Stock for at least 20 of any 30 consecutive trading days following February 14, 2024 equals or exceeds the lesser of (x) $12.50 or (y) 125% of the then applicable conversion price; (ii) 33,045 shares shall vest if the VWAP for at least 20 of any 30 consecutive trading days following February 14, 2024 equals or exceeds the lesser of (x) $15.00 or (y) 150% of the then applicable conversion price; (iii) 13,218 shares shall vest upon a change of control; and (iv) 28,601 shares shall vest upon the Issuer's submission of an IND application to the FDA. If the vesting conditions are not met prior to February 14, 2028, the earnout shares will be cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents earnout shares, each of which consist of one share of the Issuer's Common Stock, subject to forfeiture if certain vesting conditions are not satisfied. The earnout shares vest as follows: (i) 33,045 shares if the volume weighted average price (\"VWAP\") of the Common Stock for at least 20 of any 30 consecutive trading days following February 14, 2024 equals or exceeds the lesser of (x) $12.50 or (y) 125% of the then applicable conversion price; (ii) 33,045 shares shall vest if the VWAP for at least 20 of any 30 consecutive trading days following February 14, 2024 equals or exceeds the lesser of (x) $15.00 or (y) 150% of the then applicable conversion price; (iii) 13,218 shares shall vest upon a change of control; and (iv) 28,601 shares shall vest upon the Issuer's submission of an IND application to the FDA. If the vesting conditions are not met prior to February 14, 2028, the earnout shares will be cancelled."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the trustee of the Atwood-Edminster Trust dtd 4-2-2000 (the \"Atwood-Edminster Trust\") and has sole voting and disposition power with respect to the shares owned by the Atwood-Edminster Trust."}],"balance_after":100527,"source":{"system":"sec-edgar","filing":"0001213900-24-021525","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390024021525/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-16"}},{"id":1628557,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-02-21T17:55:44.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":1002,"price":1000,"value":1002000.0,"ownership":{"direct":false,"nature":"Atwood-Edminster Trust dtd 4-2-2000"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On February 14, 2024, the Atwood-Edminster Trust acquired 1,002 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 5, 2024. Each share of Series A Preferred Stock has a stated value of $1,000 and, at the option of the holder, is convertible into a number of shares of Common Stock determined by dividing (x) the value of the shares of Series A Preferred Stock, plus any additional amounts thereon as of such date of determination, by (y) the conversion price, which is currently $10.00, subject to adjustments (the \"Conversion Price\"). The Series A Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 14, 2024, the Atwood-Edminster Trust acquired 1,002 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 5, 2024. Each share of Series A Preferred Stock has a stated value of $1,000 and, at the option of the holder, is convertible into a number of shares of Common Stock determined by dividing (x) the value of the shares of Series A Preferred Stock, plus any additional amounts thereon as of such date of determination, by (y) the conversion price, which is currently $10.00, subject to adjustments (the \"Conversion Price\"). The Series A Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 14, 2024, the Atwood-Edminster Trust acquired 1,002 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 5, 2024. Each share of Series A Preferred Stock has a stated value of $1,000 and, at the option of the holder, is convertible into a number of shares of Common Stock determined by dividing (x) the value of the shares of Series A Preferred Stock, plus any additional amounts thereon as of such date of determination, by (y) the conversion price, which is currently $10.00, subject to adjustments (the \"Conversion Price\"). The Series A Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the trustee of the Atwood-Edminster Trust dtd 4-2-2000 (the \"Atwood-Edminster Trust\") and has sole voting and disposition power with respect to the shares owned by the Atwood-Edminster Trust."}],"balance_after":1002,"derivative":{"exercise_price":10,"underlying":"Common Stock","underlying_shares":100200},"source":{"system":"sec-edgar","filing":"0001213900-24-015874","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390024015874/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-16"}},{"id":1628556,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-21T17:55:44.000Z","date":"2024-02-14","kind":"other","planned":false,"acquired":true,"shares":148208,"ownership":{"direct":false,"nature":"Atwood-Edminster Trust dtd 4-2-2000"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Common Stock issued to the Atwood-Edminster Trust (as defined below) in connection with the Issuer's business combination consummated on February 14, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the trustee of the Atwood-Edminster Trust dtd 4-2-2000 (the \"Atwood-Edminster Trust\") and has sole voting and disposition power with respect to the shares owned by the Atwood-Edminster Trust."}],"balance_after":248735,"source":{"system":"sec-edgar","filing":"0001213900-24-015874","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390024015874/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-16"}},{"id":1628555,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-21T17:55:44.000Z","date":"2024-02-14","kind":"other","planned":false,"acquired":true,"shares":100527,"ownership":{"direct":false,"nature":"Atwood-Edminster Trust dtd 4-2-2000"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents earnout shares, each of which consist of one share of the Issuer's Common Stock, subject to forfeiture if certain vesting conditions are not satisfied. The earnout shares vest as follows: (i) 33,045 shares if the volume weighted average price (\"VWAP\") of the Common Stock for at least 20 of any 30 consecutive trading days following February 14, 2024 equals or exceeds the lesser of (x) $12.50 or (y) 125% of the then applicable conversion price; (ii) 33,045 shares shall vest if the VWAP for at least 20 of any 30 consecutive trading days following February 14, 2024 equals or exceeds the lesser of (x) $15.00 or (y) 150% of the then applicable conversion price; (iii) 13,218 shares shall vest upon a change of control; and (iv) 28,601 shares shall vest upon the Issuer's submission of an IND application to the FDA. If the vesting conditions are not met prior to February 14, 2028, the earnout shares will be cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents earnout shares, each of which consist of one share of the Issuer's Common Stock, subject to forfeiture if certain vesting conditions are not satisfied. The earnout shares vest as follows: (i) 33,045 shares if the volume weighted average price (\"VWAP\") of the Common Stock for at least 20 of any 30 consecutive trading days following February 14, 2024 equals or exceeds the lesser of (x) $12.50 or (y) 125% of the then applicable conversion price; (ii) 33,045 shares shall vest if the VWAP for at least 20 of any 30 consecutive trading days following February 14, 2024 equals or exceeds the lesser of (x) $15.00 or (y) 150% of the then applicable conversion price; (iii) 13,218 shares shall vest upon a change of control; and (iv) 28,601 shares shall vest upon the Issuer's submission of an IND application to the FDA. If the vesting conditions are not met prior to February 14, 2028, the earnout shares will be cancelled."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the trustee of the Atwood-Edminster Trust dtd 4-2-2000 (the \"Atwood-Edminster Trust\") and has sole voting and disposition power with respect to the shares owned by the Atwood-Edminster Trust."}],"balance_after":100527,"source":{"system":"sec-edgar","filing":"0001213900-24-015874","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390024015874/ownership.xml","form_type":"4/A","original_submission_date":"2024-02-16"}},{"id":1637926,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-02-16T19:36:23.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":1002,"price":1000,"value":1002000.0,"ownership":{"direct":false,"nature":"Atwood-Edminster Trust dtd 4-2-2000"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On February 14, 2024, the Atwood-Edminster Trust acquired 1,002 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 5, 2024. Each share of Series A Preferred Stock has a stated value of $1,000 and, at the option of the holder, is convertible into a number of shares of Common Stock determined by dividing (x) the value of the shares of Series A Preferred Stock, plus any additional amounts thereon as of such date of determination, by (y) the conversion price, which is currently $10.00, subject to adjustments (the \"Conversion Price\"). The Series A Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 14, 2024, the Atwood-Edminster Trust acquired 1,002 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 5, 2024. Each share of Series A Preferred Stock has a stated value of $1,000 and, at the option of the holder, is convertible into a number of shares of Common Stock determined by dividing (x) the value of the shares of Series A Preferred Stock, plus any additional amounts thereon as of such date of determination, by (y) the conversion price, which is currently $10.00, subject to adjustments (the \"Conversion Price\"). The Series A Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 14, 2024, the Atwood-Edminster Trust acquired 1,002 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 5, 2024. Each share of Series A Preferred Stock has a stated value of $1,000 and, at the option of the holder, is convertible into a number of shares of Common Stock determined by dividing (x) the value of the shares of Series A Preferred Stock, plus any additional amounts thereon as of such date of determination, by (y) the conversion price, which is currently $10.00, subject to adjustments (the \"Conversion Price\"). The Series A Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the trustee of the Atwood-Edminster Trust dtd 4-2-2000 (the \"Atwood-Edminster Trust\") and has sole voting and disposition power with respect to the shares owned by the Atwood-Edminster Trust."}],"balance_after":1002,"derivative":{"exercise_price":10,"underlying":"Common Stock","underlying_shares":100200},"source":{"system":"sec-edgar","filing":"0001213900-24-015024","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390024015024/ownership.xml","form_type":"4"}},{"id":1637925,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-16T19:36:23.000Z","date":"2024-02-14","kind":"other","planned":false,"acquired":true,"shares":148208,"ownership":{"direct":false,"nature":"Atwood-Edminster Trust dtd 4-2-2000"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Common Stock distributed in-kind by Phoenix Biotech Sponsor, LLC (the \"Sponsor\") to its members, pro rata and without consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the trustee of the Atwood-Edminster Trust dtd 4-2-2000 (the \"Atwood-Edminster Trust\") and has sole voting and disposition power with respect to the shares owned by the Atwood-Edminster Trust."}],"balance_after":248735,"source":{"system":"sec-edgar","filing":"0001213900-24-015024","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390024015024/ownership.xml","form_type":"4"}},{"id":1637924,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-16T19:36:23.000Z","date":"2024-02-14","kind":"other","planned":false,"acquired":true,"shares":100527,"ownership":{"direct":false,"nature":"Atwood-Edminster Trust dtd 4-2-2000"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents earnout shares, each of which consist of one share of the Issuer's Common Stock, subject to forfeiture if certain vesting conditions are not satisfied. The earnout shares vest as follows: (i) 33,045 shares if the volume weighted average price (\"VWAP\") of the Common Stock for at least 20 of any 30 consecutive trading days following February 14, 2024 equals or exceeds the lesser of (x) $12.50 or (y) 125% of the then applicable conversion price; (ii) 33,045 shares shall vest if the VWAP for at least 20 of any 30 consecutive trading days following February 14, 2024 equals or exceeds the lesser of (x) $15.00 or (y) 150% of the then applicable conversion price; (iii) 13,218 shares shall vest upon a change of control; and (iv) 28,601 shares shall vest upon the Issuer's submission of an IND application to the FDA. If the vesting conditions are not met prior to February 14, 2028, the earnout shares will be cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents earnout shares, each of which consist of one share of the Issuer's Common Stock, subject to forfeiture if certain vesting conditions are not satisfied. The earnout shares vest as follows: (i) 33,045 shares if the volume weighted average price (\"VWAP\") of the Common Stock for at least 20 of any 30 consecutive trading days following February 14, 2024 equals or exceeds the lesser of (x) $12.50 or (y) 125% of the then applicable conversion price; (ii) 33,045 shares shall vest if the VWAP for at least 20 of any 30 consecutive trading days following February 14, 2024 equals or exceeds the lesser of (x) $15.00 or (y) 150% of the then applicable conversion price; (iii) 13,218 shares shall vest upon a change of control; and (iv) 28,601 shares shall vest upon the Issuer's submission of an IND application to the FDA. If the vesting conditions are not met prior to February 14, 2028, the earnout shares will be cancelled."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is the trustee of the Atwood-Edminster Trust dtd 4-2-2000 (the \"Atwood-Edminster Trust\") and has sole voting and disposition power with respect to the shares owned by the Atwood-Edminster Trust."}],"balance_after":100527,"source":{"system":"sec-edgar","filing":"0001213900-24-015024","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390024015024/ownership.xml","form_type":"4"}},{"id":1637923,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-16T19:36:23.000Z","date":"2024-02-14","kind":"other","planned":false,"acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Common Stock distributed in-kind by Phoenix Biotech Sponsor, LLC (the \"Sponsor\") to its members, pro rata and without consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Common Stock distributed in-kind by Phoenix Biotech Sponsor, LLC (the \"Sponsor\") to its members, pro rata and without consideration."}],"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001213900-24-015024","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000121390024015024/ownership.xml","form_type":"4"}},{"id":1854105,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T18:01:51.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date.  All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control."}],"balance_after":12000,"derivative":{"exercise_price":1.18,"expiration_date":"2023-06-12","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-23-037514","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000120919123037514/doc4.xml","form_type":"4"}},{"id":2233899,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T18:11:11.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date.  All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control."}],"balance_after":12000,"derivative":{"exercise_price":2.09,"expiration_date":"2032-06-07","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-22-036431","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000120919122036431/doc4.xml","form_type":"4"}},{"id":2544328,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2021-10-12T19:28:03.000Z","date":"2021-10-08","kind":"other","acquired":true,"shares":25000,"ownership":{"direct":false,"nature":"By Phoenix Biotech Sponsor, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments described in the issuer's charter documents and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Allocated to the reporting person as a member of Phoenix Biotech Sponsor, LLC, for service on the issuer's board of directors."},{"field":"shares","element":"transactionShares","label":"F3","text":"The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for any other purpose."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Allocated to the reporting person as a member of Phoenix Biotech Sponsor, LLC, for service on the issuer's board of directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments described in the issuer's charter documents and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments described in the issuer's charter documents and have no expiration date."}],"balance_after":25000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-21-039931","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000089924321039931/doc4.xml","form_type":"4"}},{"id":2671807,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T20:51:42.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":42223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest on the one-year anniversary of the date of grant."}],"balance_after":42223,"derivative":{"exercise_price":5.97,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":42223},"source":{"system":"sec-edgar","filing":"0000899243-21-023396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321023396/doc4.xml","form_type":"4"}},{"id":2671644,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T16:36:34.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date.  All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control."}],"balance_after":12000,"derivative":{"exercise_price":10.27,"expiration_date":"2031-06-08","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-21-039853","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000120919121039853/doc4.xml","form_type":"4"}},{"id":2906972,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2021-01-14T19:45:35.000Z","date":"2021-01-12","kind":"other","acquired":false,"shares":25000,"ownership":{"direct":false,"nature":"By LWAC D&O LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments described in the issuer's charter documents and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Allocated to the reporting person as a member of LWAC D&O LLC, a member of Locust Walk Sponsor, LLC, for service on the issuer's board of directors."},{"field":"shares","element":"transactionShares","label":"F3","text":"The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for any other purpose."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Allocated to the reporting person as a member of LWAC D&O LLC, a member of Locust Walk Sponsor, LLC, for service on the issuer's board of directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments described in the issuer's charter documents and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments described in the issuer's charter documents and have no expiration date."}],"balance_after":25000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-21-002101","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000089924321002101/doc4.xml","form_type":"4"}},{"id":2949960,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-10T19:09:17.000Z","date":"2020-12-09","kind":"gift","acquired":true,"shares":34166,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Atwood-Edminster Trust dtd 4/2/00"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48 of the Option vests in equal monthly installments as measured from 5/23/2019."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"On December 9, 2020, the reporting person transferred such Non-Qualified Stock Options to Atwood-Edminster Trust dtd 4/2/00. The reporting person is a trustee and continues to report beneficial ownership of these Non-Qualified Stock Options held by the Atwood-Edminster Trust dtd 4/2/00, but disclaims beneficial ownership except to the extent of his and immediate family's pecuniary interest therein."}],"balance_after":34166,"derivative":{"exercise_price":12.66,"expiration_date":"2029-05-22","underlying":"Class A Common Stock","underlying_shares":34166},"source":{"system":"sec-edgar","filing":"0001209191-20-062799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000120919120062799/doc4.xml","form_type":"4"}},{"id":2949959,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-10T19:09:17.000Z","date":"2020-12-09","kind":"gift","acquired":false,"shares":34166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48 of the Option vests in equal monthly installments as measured from 5/23/2019."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"On December 9, 2020, the reporting person transferred such Non-Qualified Stock Options to Atwood-Edminster Trust dtd 4/2/00. The reporting person is a trustee and continues to report beneficial ownership of these Non-Qualified Stock Options held by the Atwood-Edminster Trust dtd 4/2/00, but disclaims beneficial ownership except to the extent of his and immediate family's pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":12.66,"expiration_date":"2029-05-22","underlying":"Class A Common Stock","underlying_shares":34166},"source":{"system":"sec-edgar","filing":"0001209191-20-062799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000120919120062799/doc4.xml","form_type":"4"}},{"id":2949958,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-10T19:09:17.000Z","date":"2020-12-09","kind":"gift","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Atwood-Edminster Trust dtd 4/2/00"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Option is fully vested."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"On December 9, 2020, the reporting person transferred such Non-Qualified Stock Options to Atwood-Edminster Trust dtd 4/2/00. The reporting person is a trustee and continues to report beneficial ownership of these Non-Qualified Stock Options held by the Atwood-Edminster Trust dtd 4/2/00, but disclaims beneficial ownership except to the extent of his and immediate family's pecuniary interest therein."}],"balance_after":12500,"derivative":{"exercise_price":4.56,"expiration_date":"2026-07-19","underlying":"Class A Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-20-062799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000120919120062799/doc4.xml","form_type":"4"}},{"id":2949957,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-10T19:09:17.000Z","date":"2020-12-09","kind":"gift","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Option is fully vested."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"On December 9, 2020, the reporting person transferred such Non-Qualified Stock Options to Atwood-Edminster Trust dtd 4/2/00. The reporting person is a trustee and continues to report beneficial ownership of these Non-Qualified Stock Options held by the Atwood-Edminster Trust dtd 4/2/00, but disclaims beneficial ownership except to the extent of his and immediate family's pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":4.56,"expiration_date":"2026-07-19","underlying":"Class A Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-20-062799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000120919120062799/doc4.xml","form_type":"4"}},{"id":2949956,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-10T19:09:17.000Z","date":"2020-12-09","kind":"gift","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Atwood-Edminster Trust dtd 4/2/00"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date.  All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"On December 9, 2020, the reporting person transferred such Non-Qualified Stock Options to Atwood-Edminster Trust dtd 4/2/00. The reporting person is a trustee and continues to report beneficial ownership of these Non-Qualified Stock Options held by the Atwood-Edminster Trust dtd 4/2/00, but disclaims beneficial ownership except to the extent of his and immediate family's pecuniary interest therein."}],"balance_after":12000,"derivative":{"exercise_price":17.87,"expiration_date":"2030-06-09","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-20-062799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000120919120062799/doc4.xml","form_type":"4"}},{"id":2949955,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-10T19:09:17.000Z","date":"2020-12-09","kind":"gift","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date.  All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"On December 9, 2020, the reporting person transferred such Non-Qualified Stock Options to Atwood-Edminster Trust dtd 4/2/00. The reporting person is a trustee and continues to report beneficial ownership of these Non-Qualified Stock Options held by the Atwood-Edminster Trust dtd 4/2/00, but disclaims beneficial ownership except to the extent of his and immediate family's pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":17.87,"expiration_date":"2030-06-09","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-20-062799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000120919120062799/doc4.xml","form_type":"4"}},{"id":2986437,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-10T19:39:48.000Z","date":"2020-11-09","kind":"exercise","acquired":false,"shares":6896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option were fully vested as of the date of exercise."}],"balance_after":0,"derivative":{"exercise_price":3.08,"expiration_date":"2020-12-01","underlying":"Common Stock","underlying_shares":6896},"source":{"system":"sec-edgar","filing":"0000899243-20-030747","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320030747/doc4.xml","form_type":"4"}},{"id":2986436,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-10T19:39:48.000Z","date":"2020-11-09","kind":"exercise","acquired":true,"shares":6896,"price":3.08,"value":21239.68,"ownership":{"direct":true},"balance_after":32758,"source":{"system":"sec-edgar","filing":"0000899243-20-030747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320030747/doc4.xml","form_type":"4"}},{"id":3110356,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-15T17:08:30.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date.  All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control."}],"balance_after":12000,"derivative":{"exercise_price":17.87,"expiration_date":"2030-06-09","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-20-036668","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000120919120036668/doc4.xml","form_type":"4"}},{"id":3120321,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-05T17:04:05.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":40138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth (1/12) of the shares subject to the option shall vest on each of the first twelve (12) monthly anniversaries of the date of grant."}],"balance_after":40138,"derivative":{"exercise_price":6.48,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":40138},"source":{"system":"sec-edgar","filing":"0000899243-20-015506","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320015506/doc4.xml","form_type":"4"}},{"id":3431111,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-08-22T16:15:19.000Z","date":"2019-08-20","kind":"exercise","acquired":false,"shares":25862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was immediately exercisable as to both vested and unvested shares. 25% of the shares subject to the option vested on each of August 26, 2009, August 26, 2010, August 26, 2011 and August 26, 2012."}],"balance_after":0,"derivative":{"exercise_price":0.29,"expiration_date":"2019-08-26","underlying":"Common Stock","underlying_shares":25862},"source":{"system":"sec-edgar","filing":"0000899243-19-022285","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924319022285/doc4.xml","form_type":"4"}},{"id":3431110,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-22T16:15:19.000Z","date":"2019-08-20","kind":"exercise","acquired":true,"shares":25862,"price":0.29,"value":7499.98,"ownership":{"direct":true},"balance_after":25862,"source":{"system":"sec-edgar","filing":"0000899243-19-022285","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924319022285/doc4.xml","form_type":"4"}},{"id":3479942,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-06-24T16:44:07.000Z","date":"2019-06-24","kind":"exercise","acquired":false,"shares":4287,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Atwood-Edminster Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4287},"source":{"system":"sec-edgar","filing":"0001209191-19-038781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000120919119038781/doc4.xml","form_type":"4"}},{"id":3479941,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-06-24T16:44:07.000Z","date":"2019-06-24","kind":"exercise","acquired":false,"shares":4504,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Atwood-Edminster Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4504},"source":{"system":"sec-edgar","filing":"0001209191-19-038781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000120919119038781/doc4.xml","form_type":"4"}},{"id":3479940,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-06-24T16:44:07.000Z","date":"2019-06-24","kind":"exercise","acquired":true,"shares":8791,"ownership":{"direct":false,"nature":"By Atwood-Edminster Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date."}],"balance_after":49654,"source":{"system":"sec-edgar","filing":"0001209191-19-038781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1266567/000120919119038781/doc4.xml","form_type":"4"}},{"id":3497109,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-07T16:46:28.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":28882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth (1/12) of the shares subject to the option shall vest on each of the first twelve (12) monthly anniversaries of the date of grant."}],"balance_after":2882,"derivative":{"exercise_price":14.66,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":28882},"source":{"system":"sec-edgar","filing":"0000899243-19-016037","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924319016037/doc4.xml","form_type":"4"}},{"id":3790641,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-10-15T18:48:10.000Z","date":"2018-10-11","kind":"grant","acquired":true,"shares":14770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth (1/12) of the shares subject to the option shall vest on each of the first twelve (12) monthly anniversaries of the date of grant."}],"balance_after":14770,"derivative":{"exercise_price":27.92,"expiration_date":"2028-10-11","underlying":"Common Stock","underlying_shares":14770},"source":{"system":"sec-edgar","filing":"0000899243-18-026723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924318026723/doc4.xml","form_type":"4"}},{"id":4271023,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-28T18:53:21.000Z","date":"2017-06-26","kind":"other","acquired":true,"shares":4998,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership by virtue of the receipt of shares in the pro-rata distribution of Common Stock of the Issuer by Versant Ventures IV, LLC without consideration to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by the Atwood-Edminster Trust dated 4/2/2000 (the \"Trust\"). Brian G. Atwood (the \"Reporting Person\") is a trustee and a named beneficiary of the Trust.  The Reporting Person disclaims beneficial ownership of these shares except to the extent of his proportionate pecuniary interest therein."}],"balance_after":25577,"source":{"system":"sec-edgar","filing":"0001104659-17-042168","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000110465917042168/a4.xml","form_type":"4"}},{"id":4271022,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-28T18:53:21.000Z","date":"2017-06-26","kind":"other","acquired":true,"shares":212,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a change in the form of ownership by virtue of the receipt of shares in the pro-rata distribution of Common Stock of the Issuer by Versant Side Fund IV, L.P. without consideration to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by the Atwood-Edminster Trust dated 4/2/2000 (the \"Trust\"). Brian G. Atwood (the \"Reporting Person\") is a trustee and a named beneficiary of the Trust.  The Reporting Person disclaims beneficial ownership of these shares except to the extent of his proportionate pecuniary interest therein."}],"balance_after":20579,"source":{"system":"sec-edgar","filing":"0001104659-17-042168","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000110465917042168/a4.xml","form_type":"4"}},{"id":4288344,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-08T17:42:40.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth (1/12) of the shares subject to the option shall vest on each of the first twelve (12) monthly anniversaries of the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":59.56,"expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-17-015812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924317015812/doc4.xml","form_type":"4"}},{"id":4301164,"issuer":{"id":174777,"kind":"organization","name":"PHASERX, INC.","symbol":"PZRX"},"owners":[{"id":69648,"kind":"person","name":"ATWOOD BRIAN G","position":1,"cik":"0001266567","reported_name":"ATWOOD BRIAN G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-05-30T17:49:46.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 25, 2017, the reporting person was granted an option to purchase shares of common stock. The option vests in 1/12th equal installments on each monthly anniversary of May 25, 2017, and subject to the reporting person's continued service to the Issuer."}],"balance_after":14000,"derivative":{"exercise_price":1.0799,"expiration_date":"2027-05-25","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001144204-17-030196","document":"v468058_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429386/000114420417030196/v468058_form4.xml","form_type":"4"}}]}